S Rivas-Vilela1, J Rubió-Casadevall1,2,3, A Fàbrega-Ribas1, C Joly-Torta3,4, L Vilardell1,5, R Marcos-Gragera6,7,8,9. 1. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. 2. Medical Oncology Department, Catalan Institute of Oncology, Girona, Spain. 3. School of Medicine, University of Girona (UdG), Girona, Spain. 4. Department of Neuro-surgery, University Hospital Josep Trueta, Girona, Catalan Institute of Health, Girona, Spain. 5. Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health Government of Catalonia, Catalan Institute of Oncology, Girona, Spain. 6. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. rmarcos@iconcologia.net. 7. School of Medicine, University of Girona (UdG), Girona, Spain. rmarcos@iconcologia.net. 8. Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health Government of Catalonia, Catalan Institute of Oncology, Girona, Spain. rmarcos@iconcologia.net. 9. CIBER Epidemiología y Salud Pública, Madrid, Spain. rmarcos@iconcologia.net.
Abstract
INTRODUCTION: Pediatric central nervous system tumors are one of the most frequent types of neoplasms in children but epidemiological data on these tumors have been sparsely reported in the medical literature. MATERIALS AND METHODS: We analyze the epidemiology of this type of tumors performing a retrospective population-based study in pediatrics and adolescent age in the population of Girona and compare them with series from Spain, Europe and worldwide. Cases were registered using the International Classification of Disease for Oncology, third edition and grouping according the International Classification of Childhood Cancer, third edition (ICCC-3). RESULTS: For all the histologies and the whole population between 0 and 19 years old, ASRw was 41.8 cases per million person-years. In children population, meaning under 14 years old, we found 104 cases with ASRw of 45.6. Males were the most affected by CNS tumors with a 1.2 sex ratio between 0 and 14 years old, and 1.1 between 0 and 19 years old. The analysis of trends in incidence did not find any statistically significant increase or decrease. Five-year observed survival was 68%, both for patients under 19 and 14 years of age. CONCLUSIONS: The incidence in our area was among the highest in Spain and worldwide, while survival was comparable to others reported.
INTRODUCTION:Pediatric central nervous system tumors are one of the most frequent types of neoplasms in children but epidemiological data on these tumors have been sparsely reported in the medical literature. MATERIALS AND METHODS: We analyze the epidemiology of this type of tumors performing a retrospective population-based study in pediatrics and adolescent age in the population of Girona and compare them with series from Spain, Europe and worldwide. Cases were registered using the International Classification of Disease for Oncology, third edition and grouping according the International Classification of Childhood Cancer, third edition (ICCC-3). RESULTS: For all the histologies and the whole population between 0 and 19 years old, ASRw was 41.8 cases per million person-years. In children population, meaning under 14 years old, we found 104 cases with ASRw of 45.6. Males were the most affected by CNS tumors with a 1.2 sex ratio between 0 and 14 years old, and 1.1 between 0 and 19 years old. The analysis of trends in incidence did not find any statistically significant increase or decrease. Five-year observed survival was 68%, both for patients under 19 and 14 years of age. CONCLUSIONS: The incidence in our area was among the highest in Spain and worldwide, while survival was comparable to others reported.
Authors: C A Stiller; R Marcos-Gragera; E Ardanaz; F Pannelli; E Almar Marqués; A Cañada Martinez; E Steliarova-Foucher Journal: Eur J Cancer Date: 2006-09 Impact factor: 9.162
Authors: David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison Journal: Acta Neuropathol Date: 2016-05-09 Impact factor: 17.088
Authors: G Coll; J-D Combes; F Isfan; E Rochette; J Chazal; J-J Lemaire; E de Schlichting; J Kanold Journal: Neurochirurgie Date: 2015-06-26 Impact factor: 1.553
Authors: G Gatta; R Peris-Bonet; O Visser; C Stiller; R Marcos-Gragera; M-J Sánchez; B Lacour; P Kaatsch; F Berrino; S Rutkowski; L Botta Journal: Eur J Cancer Date: 2017-07-06 Impact factor: 9.162
Authors: Betsy A Kohler; Elizabeth Ward; Bridget J McCarthy; Maria J Schymura; Lynn A G Ries; Christie Eheman; Ahmedin Jemal; Robert N Anderson; Umed A Ajani; Brenda K Edwards Journal: J Natl Cancer Inst Date: 2011-03-31 Impact factor: 13.506
Authors: Eduardo Javier Barragán-Pérez; Carlos Enrique Altamirano-Vergara; Daniel Eduardo Alvarez-Amado; Juan Carlos García-Beristain; Fernando Chico-Ponce-de-León; Vicente González-Carranza; Luis Juárez-Villegas; Chiharu Murata Journal: Pathol Oncol Res Date: 2020-07-13 Impact factor: 2.874